{
    "eid": "2-s2.0-85086008016",
    "title": "Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial",
    "cover-date": "2020-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Agricultural and Biological Sciences (all)",
            "@code": "1100",
            "@abbrev": "AGRI"
        },
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Ngamjit Kasetsuwan",
        "Kanawat Chantaralawan",
        "Usanee Reinprayoon",
        "Lita Uthaithammarat"
    ],
    "citedby-count": 6,
    "ref-count": 25,
    "ref-list": [
        "The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workshop (2007)",
        "Efficiency and safety of subconjunctival injection of anti-VEGF agent\u2014bevacizumab\u2014in treating dry eye",
        "Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis",
        "Clinical and molecular inflammatory response in Sjogren syndrome-associated dry eye patients under desiccating stress",
        "Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: Prospects for therapeutic intervention",
        "VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment",
        "Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease",
        "Short- And long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization",
        "Minimal clinically important difference for the ocular surface disease index",
        "Grading of corneal and conjunctival staining in the context of other dry eye tests",
        "Dry eye disease: An immune-mediated ocular surface disorder",
        "TFOS DEWS II pathophysiology report",
        "Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies",
        "Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease",
        "Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients",
        "Role of VEGF-A in chronic pain",
        "Central VEGF-A pathway plays a key role in the development of trigeminal neuropathic pain in rats",
        "Correlation between liver cancer pain and the HIF-1 and VEGF expression levels",
        "TFOS DEWS II pain and sensation report",
        "Painful understanding of VEGF",
        "Associations between signs and symptoms of dry eye disease: A systematic review",
        "Association between dry eye symptoms and signs",
        "Dry eye disease: Concordance between the diagnostic tests in African eyes",
        "Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology",
        "Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: A Systematic Review and Meta-analysis"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}